167 related articles for article (PubMed ID: 21980493)
1. Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.
Naudin C; Joulin-Giet A; Couetdic G; Plésiat P; Szymanska A; Gorna E; Gauthier F; Kasprzykowski F; Lecaille F; Lalmanach G
PLoS One; 2011; 6(9):e25577. PubMed ID: 21980493
[TBL] [Abstract][Full Text] [Related]
2. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties.
Lecaille F; Naudin C; Sage J; Joulin-Giet A; Courty A; Andrault PM; Veldhuizen RA; Possmayer F; Lalmanach G
Int J Biochem Cell Biol; 2013 Aug; 45(8):1701-9. PubMed ID: 23707200
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.
Andrault PM; Samsonov SA; Weber G; Coquet L; Nazmi K; Bolscher JG; Lalmanach AC; Jouenne T; Brömme D; Pisabarro MT; Lalmanach G; Lecaille F
Biochemistry; 2015 May; 54(17):2785-98. PubMed ID: 25884905
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
[TBL] [Abstract][Full Text] [Related]
5. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids.
Serveau-Avesque C; Martino MF; Hervé-Grépinet V; Hazouard E; Gauthier F; Diot E; Lalmanach G
Biol Cell; 2006 Jan; 98(1):15-22. PubMed ID: 16354158
[TBL] [Abstract][Full Text] [Related]
6. miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.
Weldon S; McNally P; McAuley DF; Oglesby IK; Wohlford-Lenane CL; Bartlett JA; Scott CJ; McElvaney NG; Greene CM; McCray PB; Taggart CC
Am J Respir Crit Care Med; 2014 Jul; 190(2):165-74. PubMed ID: 24940638
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
8. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia.
Altiok O; Yasumatsu R; Bingol-Karakoc G; Riese RJ; Stahlman MT; Dwyer W; Pierce RA; Bromme D; Weber E; Cataltepe S
Am J Respir Crit Care Med; 2006 Feb; 173(3):318-26. PubMed ID: 16166622
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.
Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G
J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333
[TBL] [Abstract][Full Text] [Related]
11. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
12. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.
Rogan MP; Taggart CC; Greene CM; Murphy PG; O'Neill SJ; McElvaney NG
J Infect Dis; 2004 Oct; 190(7):1245-53. PubMed ID: 15346334
[TBL] [Abstract][Full Text] [Related]
13. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
14. Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.
Barthe C; Nandakumar S; Derlich L; Macey J; Bui S; Fayon M; Crouzet M; Garbay B; Vilain S; Costaglioli P
Lett Appl Microbiol; 2015 Nov; 61(5):423-8. PubMed ID: 26174137
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
Taggart CC; Greene CM; Smith SG; Levine RL; McCray PB; O'Neill S; McElvaney NG
J Immunol; 2003 Jul; 171(2):931-7. PubMed ID: 12847264
[TBL] [Abstract][Full Text] [Related]
16. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
18. Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa.
Dong Z; Katar M; Linebaugh BE; Sloane BF; Berk RS
Eur J Biochem; 2001 Dec; 268(24):6408-16. PubMed ID: 11737195
[TBL] [Abstract][Full Text] [Related]
19. Association of airway cathepsin B and S with inflammation in cystic fibrosis.
Martin SL; Moffitt KL; McDowell A; Greenan C; Bright-Thomas RJ; Jones AM; Webb AK; Elborn JS
Pediatr Pulmonol; 2010 Sep; 45(9):860-8. PubMed ID: 20632407
[TBL] [Abstract][Full Text] [Related]
20. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
